Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.

× No keyword cloud information.

35 in total

1. Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Authors: Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Journal: J Clin Oncol Date: 2010-06-07 Impact factor: 44.544

2. Improving outcomes in cholangiocarcinomas.

Authors: Charles Imber; Justin Stebbing; Arjun Shankar
Journal: Gastrointest Cancer Res Date: 2011-09

3. Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancer.

Authors: Myung-Ah Lee; Jae-Ho Byun; Byoung-Young Shim; In-Sook Woo; Jin-Hyung Kang; Young Seon Hong; Kyung Shik Lee; Myung Gyu Choi; Suk Kyun Chang; Seong Taek Oh; Sung Il Choi; Doo Suk Lee
Journal: Korean J Intern Med Date: 2005-09 Impact factor: 2.884

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.

1. Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

2. Improving outcomes in cholangiocarcinomas.

3. Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancer.

4. Balancing the efficacy and toxicity of chemotherapy in colorectal cancer.

Review 5. Optical molecular imaging and its emerging role in colorectal cancer.

Review 6. The role of targeted therapy in the treatment of advanced colorectal cancer.

7. Survival of untreated advanced colorectal cancer patients.

Review 8. Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?

Review 9. First-line treatment strategies to improve survival in patients with advanced colorectal cancer.

Review 10. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation.